Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 3 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 111 Carboplatin 45 Nivolumab 41 Paclitaxel 34 Cyclophosphamide 32 Cisplatin 32 Gemcitabine 30 atezolizumab 27 Specimen Handling 25 venetoclax 24 Magnetic Resonance Spectroscopy 24 Pemetrexed 23 fludarabine 22 Biopsy 22 Radiotherapy 21 Ipilimumab 21 Docetaxel 21 Bevacizumab 21 Azacitidine 21 Radiosurgery 18 durvalumab 17 Fluorouracil 17 Dexamethasone 17 Cetuximab 16 fludarabine phosphate 14 Trastuzumab 14 Leucovorin 13 Cytarabine 13 tislelizumab 12 olaparib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × NKTR-255 × 1 year × Clear all

NCT05676749 2026-01-05

C-TIL051 in Non-Small Cell Lung Cancer

AbelZeta Inc.

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡